Medicare:
Indirect Medical Education Payments Are Too High
T-HRD-89-14: Published: Apr 11, 1989. Publicly Released: Apr 11, 1989.
Additional Materials:
- Full Report:
Contact:
GAO discussed Medicare's indirect medical education payments to teaching hospitals. GAO found that: (1) the Prospective Payment System (PPS) set payment rates for hospital operating costs based on diagnosis-related groups and hospital standard payments; (2) hospitals could receive higher PPS payments by treating a disproportionate share of low-income Medicare beneficiaries and additional payments by conducting graduate medical education programs; (3) teaching hospitals received 106-percent higher payments per discharge and had 95-percent higher costs per discharge than nonteaching hospitals, while minor teaching hospitals received 45-percent higher payments per discharge and had 40-percent higher discharge costs; (4) estimates of indirect teaching costs per Medicare discharge ranged from 3.73 percent to 7.19 percent and all of the estimates were lower than the statutory 7.65-percent adjustment factor; (5) most of the differences in hospital costs related to input prices, outputs, and efficiency, rather than to teaching; (6) after these factors, the indirect cost of medical education accounted for the remaining differences in the teaching hospitals' higher costs; and (7) because the amount paid to hospitals remained the same after adjustments for particular hospitals or groups of hospitals, higher payments to teaching hospitals resulted in lower payments to nonteaching hospitals. GAO believes that Congress should reduce the teaching adjustment factor for 1989 and beyond to 5.09 percent.
Oct 26, 2020
-
Anesthesia Services:
Differences between Private and Medicare Payments Likely Due to Providers’ Strong Negotiating PositionGAO-21-41: Published: Oct 26, 2020. Publicly Released: Oct 26, 2020.
Oct 19, 2020
-
VA Health Care:
Better Data Needed to Assess the Health Outcomes of Lesbian, Gay, Bisexual, and Transgender VeteransGAO-21-69: Published: Oct 19, 2020. Publicly Released: Oct 19, 2020.
Oct 8, 2020
-
Laboratory Safety:
FDA Should Strengthen Efforts to Provide Effective OversightGAO-20-594: Published: Sep 8, 2020. Publicly Released: Oct 8, 2020.
Oct 1, 2020
-
Prescription Drug Monitoring Programs:
Views on Usefulness and Challenges of ProgramsGAO-21-22: Published: Oct 1, 2020. Publicly Released: Oct 1, 2020.
Sep 30, 2020
-
VA Acquisition Management:
Actions Needed to Improve Management of Medical-Surgical Prime Vendor Program and Inform Future DecisionsGAO-20-487: Published: Sep 30, 2020. Publicly Released: Sep 30, 2020.
Sep 23, 2020
-
VA Vet Centers:
Evaluations Needed of Expectations for Counselor Productivity and Centers' StaffingGAO-20-652: Published: Sep 23, 2020. Publicly Released: Sep 23, 2020.
Sep 21, 2020
-
COVID-19:
Federal Efforts Could Be Strengthened by Timely and Concerted ActionsGAO-20-701: Published: Sep 21, 2020. Publicly Released: Sep 21, 2020.
Sep 17, 2020
-
Defense Health Care:
Implementation of Value-Based Initiatives in TRICAREGAO-20-695R: Published: Sep 17, 2020. Publicly Released: Sep 17, 2020.
Sep 16, 2020
-
Private Health Coverage:
Results of Covert Testing for Selected OfferingsGAO-20-634R: Published: Aug 24, 2020. Publicly Released: Sep 16, 2020.
Sep 14, 2020
-
Public Health Preparedness:
Information on the Use of Medical Reserve Corps Volunteers during EmergenciesGAO-20-630: Published: Sep 14, 2020. Publicly Released: Sep 14, 2020.
Looking for more? Browse all our products here

Explore our Key Issues on Health Care